Embecta Corp. (EMBC) vs Opus Genetics, Inc. (IRD)

A side-by-side comparison of Embecta Corp. and Opus Genetics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Embecta Corp. logo
EMBC
Embecta Corp.
$353M
$5.95HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT
Opus Genetics, Inc. logo
IRD
Opus Genetics, Inc.
$349M
$4.23HealthcareDelayed quote: Oct 6, 2026, 10:35 AM EDT

Total return — EMBC vs IRD

growth of $100 · dividends reinvested · last 2y
EMBC -57.9% (-35.1%/yr)IRD +239.5% (+84.3%/yr)IRD compounded faster over this window
Log scale — wide-divergence pair
101001kStart $10020252026$42$340
EMBC IRD

EMBC vs IRD: by the numbers

  • •EMBC is the larger company ($353M vs $349M market cap).
  • •EMBC is profitable (8.59% net margin) while IRD runs a net loss (-1091.82%).
  • •IRD grew revenue faster over the past five years (150.49% vs -0.09% CAGR).
  • •EMBC pays a dividend (5.44% yield), while IRD has no payments in the available dividend history.

Metrics side by side

Valuation

MetricEMBCIRD
P/E ratio4.02N/A
Forward P/E3.38N/A
P/S ratio0.3535.41
EV / EBITDA5.38N/A
FCF yield46.63%N/A

Profitability

MetricEMBCIRD
Gross margin59.89%99.87%
Operating margin24.85%-271.90%
Net margin8.59%-1091.82%
ROIC17.99%-59.29%

Dividends

MetricEMBCIRD
Dividend yield5.44%N/A
Payout ratio21.62%N/A

Growth (annualized)

MetricEMBCIRD
Revenue CAGR (5Y)-0.09%150.49%
EPS CAGR (5Y)-26.22%N/A
FCF CAGR (5Y)-16.77%N/A

Frequently asked

Which has grown faster, EMBC or IRD?
Over the past five years, IRD grew revenue faster — EMBC at a -0.09% CAGR versus IRD at 150.49%.
Does EMBC or IRD pay a bigger dividend?
EMBC pays a dividend (5.44% yield), while IRD has no payments in the available dividend history.
Is EMBC or IRD more profitable?
EMBC runs the higher net margin — EMBC at 8.59% versus IRD at -1091.82%.

Go deeper

Full EMBC analysisFull IRD analysisInteractive comparison tool

Dig into the metrics

Embecta P/E ratioEmbecta dividend yieldEmbecta ROEOpus Genetics ROEEmbecta operating marginOpus Genetics operating marginEmbecta revenue growthOpus Genetics revenue growthEmbecta free cash flowOpus Genetics free cash flow

Embecta & Opus Genetics appear in these rankings

Highest Dividend Yield StocksFastest Revenue Growth StocksHighest FCF Yield StocksLowest P/E Ratio Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.